These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22729371)

  • 1. Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats.
    Miyaji Y; Kasuya Y; Furuta Y; Kurihara A; Takahashi M; Ogawara K; Izumi T; Okazaki O; Higaki K
    Pharm Res; 2012 Nov; 29(11):3143-55. PubMed ID: 22729371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liver.
    Saito-Yabe M; Kasuya Y; Yoshigae Y; Yamamura N; Suzuki Y; Fukuda N; Honma M; Yano K; Mochizuki S; Okada F; Okada A; Nagayama Y; Tsuda E; Fischer T; Höpner U; Zaja S; Mueller J; Okada J; Kurihara A; Ikeda T; Okazaki O
    J Pharm Pharmacol; 2010 Aug; 62(8):985-94. PubMed ID: 20663032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Polymer Architecture on the Activity of Polymer-Protein Conjugates for the Treatment of Accelerated Bone Loss Disorders.
    Tucker BS; Stewart JD; Aguirre JI; Holliday LS; Figg CA; Messer JG; Sumerlin BS
    Biomacromolecules; 2015 Aug; 16(8):2374-81. PubMed ID: 26151628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved bone delivery of osteoprotegerin by bisphosphonate conjugation in a rat model of osteoarthritis.
    Doschak MR; Kucharski CM; Wright JE; Zernicke RF; Uludağ H
    Mol Pharm; 2009; 6(2):634-40. PubMed ID: 19718808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alendronate (ALN) combined with osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats.
    Wang Y; Huang P; Tang PF; Chan KM; Li G
    J Orthop Surg Res; 2011 Jul; 6():34. PubMed ID: 21752290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoprotegerin gene-modified BMSCs with hydroxyapatite scaffold for treating critical-sized mandibular defects in ovariectomized osteoporotic rats.
    Liu X; Bao C; Xu HHK; Pan J; Hu J; Wang P; Luo E
    Acta Biomater; 2016 Sep; 42():378-388. PubMed ID: 27318268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant receptor activator of nuclear factor κB exhibits more marked inhibitory effects on osteoclasts compared with recombinant osteoprotegerin in vitro and in vivo.
    Xiong Q; Xin L; Zhang L; Tang P; Zhang L
    Mol Med Rep; 2015 Jul; 12(1):631-8. PubMed ID: 25738879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiosteoclastic bone resorption activity of osteoprotegerin via enhanced AKT/mTOR/ULK1-mediated autophagic pathway.
    Zhao H; Sun Z; Ma Y; Song R; Yuan Y; Bian J; Gu J; Liu Z
    J Cell Physiol; 2020 Mar; 235(3):3002-3012. PubMed ID: 31535378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway.
    Hou JM; Xue Y; Lin QM
    Acta Pharmacol Sin; 2012 Oct; 33(10):1277-84. PubMed ID: 22902986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salidroside Improves Bone Histomorphology and Prevents Bone Loss in Ovariectomized Diabetic Rats by Upregulating the OPG/RANKL Ratio.
    Zheng H; Qi S; Chen C
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30235836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor.
    Ohishi M; Chiusaroli R; Ominsky M; Asuncion F; Thomas C; Khatri R; Kostenuik P; Schipani E
    Am J Pathol; 2009 Jun; 174(6):2160-71. PubMed ID: 19389927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats.
    Wang FS; Wang CJ; Chen YJ; Huang YT; Huang HC; Chang PR; Sun YC; Yang KD
    Endocrinology; 2004 May; 145(5):2148-56. PubMed ID: 14962990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based development of an osteoprotegerin-like glycopeptide that blocks RANKL/RANK interactions and reduces ovariectomy-induced bone loss in mice.
    Liu C; Chen X; Zhi X; Weng W; Li Q; Li X; Zou Y; Su J; Hu HG
    Eur J Med Chem; 2018 Feb; 145():661-672. PubMed ID: 29348072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoprotegerin influences the bone resorption activity of osteoclasts.
    Fu YX; Gu JH; Zhang YR; Tong XS; Zhao HY; Yuan Y; Liu XZ; Bian JC; Liu ZP
    Int J Mol Med; 2013 Jun; 31(6):1411-7. PubMed ID: 23563320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bu‑Shen‑Ning‑Xin decoction suppresses osteoclastogenesis by modulating RANKL/OPG imbalance in the CD4+ T lymphocytes of ovariectomized mice.
    Zhang JL; Qiu XM; Zhang N; Tang W; Gober HJ; Li DJ; Wang L
    Int J Mol Med; 2018 Jul; 42(1):299-308. PubMed ID: 29717766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a proton pump inhibitor on bone metabolism in ovariectomized rats.
    Joo MK; Park JJ; Lee BJ; Kim JH; Yeon JE; Kim JS; Byun KS; Bak YT
    Mol Med Rep; 2013 Apr; 7(4):1267-72. PubMed ID: 23426758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoprotegerin administration reduces femural bone loss in ovariectomized mice via impairment of osteoclast structure and function.
    Shimizu-Ishiura M; Kawana F; Sasaki T
    J Electron Microsc (Tokyo); 2002; 51(5):315-25. PubMed ID: 12455916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsed electromagnetic field stimulates osteoprotegerin and reduces RANKL expression in ovariectomized rats.
    Zhou J; Chen S; Guo H; Xia L; Liu H; Qin Y; He C
    Rheumatol Int; 2013 May; 33(5):1135-41. PubMed ID: 22948539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.